Roger Chen is Co-Founder and CEO of Onyx Bio, a pioneering biotech research collective building a virtual immune system to accelerate and de-risk the development of precision medicines.

Roger earned a B.S. in Electrical Engineering from Boston University and a Ph.D. in Electrical Engineering from UC Berkeley, where he also conducted novel nanoscale and quantum optics research.

Prior to Onyx Bio, Roger served as a Principal at O'Reilly AlphaTech Ventures investing in early-stage data, machine learning, and robotics startups, and founded Computable, a data and AI model marketplace.

Roger also served as Program Chair for the O'Reilly Artificial Intelligence Conference and has engineered at Oracle, EMC, and Vicor, giving him deep technical and operational expertise across AI and biotech.

Onyx Bio has raised an $8M seed round led by Dimension Capital with participation from Haystack, Refactor Capital, and Robot Ventures, and has already enrolled nearly a thousand members into its longitudinal immune system studies.